Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2971 AL 2985

The MMP-2/TIMP-2 System in Alzheimer Disease

Wang H, Huang L, Wu L, Lan J, Feng X, Li P, Peng Y.

CNS Neurol Disord Drug Targets. 2020;19(6):402-416. doi: 10.2174/1871527319666200812223007.

Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval

Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M.

Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.

A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds

Cao D, Jiang D, Zhou D, Yu H, Li J.

Biomed Res Int. 2020 Aug 5;2020:5016706. doi: 10.1155/2020/5016706. eCollection 2020.

Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease

Quach TT, Moutal A, Khanna R, Deems NP, Duchemin AM, Barrientos RM.

J Alzheimers Dis. 2020;77(3):949-960. doi: 10.3233/JAD-200721.

NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease

Shi JQ, Wang BR, Jiang T, Gao L, Zhang YD, Xu J.

J Alzheimers Dis. 2020;77(3):923-934. doi: 10.3233/JAD-200359.

Expanded access: opening doors to personalized medicine for rare disease patients and patients with neurodegenerative diseases

Özdinler PH.

FEBS J. 2021 Mar;288(5):1457-1461. doi: 10.1111/febs.15529. Epub 2020 Sep 5.

Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y.

Int J Mol Sci. 2020 Aug 12;21(16):5783. doi: 10.3390/ijms21165783.

The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy

Tang KS.

Life Sci. 2020 Oct 15;259:118287. doi: 10.1016/j.lfs.2020.118287. Epub 2020 Aug 16.

Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease

Koçyiğit ÜM, Gezegen H, Taslimi P.

Arch Pharm (Weinheim). 2020 Dec;353(12):e2000202. doi: 10.1002/ardp.202000202. Epub 2020 Aug 20.

Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer's Disease: A Recent Update

Pandey M, Choudhury H, Verma RK, Chawla V, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW.

CNS Neurol Disord Drug Targets. 2020;19(9):648-662. doi: 10.2174/1871527319999200819095620.

ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis

Ebanks B, Ingram TL, Chakrabarti L.

Aging (Albany NY). 2020 Aug 27;12(16):16647-16662. doi: 10.18632/aging.103867. Epub 2020 Aug 27.

Shared signaling pathways in Alzheimer's and metabolic disease may point to new treatment approaches

Suresh J, Khor IW, Kaur P, Heng HL, Torta F, Dawe GS, Tai ES, Tolwinski NS.

FEBS J. 2021 Jun;288(12):3855-3873. doi: 10.1111/febs.15540. Epub 2020 Sep 10.

A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?

Esterline R, Oscarsson J, Burns J.

Int Rev Neurobiol. 2020;155:113-140. doi: 10.1016/bs.irn.2020.03.018. Epub 2020 Aug 11.

Therapeutic potentials of neural stem cells in Alzheimer's disease

Wong RSY, Cheong SK.

Malays J Pathol. 2020 Aug;42(2):157-170.

Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules

Gupta S, Nair A, Jhawat V, Mustaq N, Sharma A, Dhanawat M, Khan SA.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520937542. doi: 10.1177/1533317520937542.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias